Home Press Releases Foot and Mouth Disease Vaccines Market size to Reach USD 4.29 Billion by 2031, Driven by Preventive Immunization Shift and Rising Livestock Trade
e

Foot and Mouth Disease Vaccines Market size to Reach USD 4.29 Billion by 2031, Driven by Preventive Immunization Shift and Rising Livestock Trade

by admin


Mordor Intelligence has published a new report on the foot and mouth disease vaccines market, offering a comprehensive analysis of trends, growth drivers, and future projections 

Foot and Mouth Disease Vaccines Market Overview 

According to Mordor Intelligence, the foot and mouth disease vaccines market size was valued at USD 2.87 billion in 2025 and is estimated to grow from USD 3.07 billion in 2026 to reach USD 4.29 billion by 2031, registering a CAGR of 6.94% during the forecast period. The rising focus on routine vaccination programs rather than outbreak-based responses is shaping the market growth across major livestock economies. 

The foot and mouth disease vaccines industry is witnessing steady demand due to increasing livestock trade, changing climatic conditions, and government-led vaccination initiatives. As the disease spreads into regions that were previously less affected, authorities are prioritizing structured immunization strategies, contributing to consistent procurement cycles. This shift is also improving predictability in supply planning and supporting long-term investments across the market. 

Key Trends in the Foot and Mouth Disease Vaccines Market 

Shift Toward Preventive Immunization Programs 

A major trend in the foot and mouth disease vaccines market is the move from reactive vaccination during outbreaks to routine preventive immunization. Governments and veterinary authorities are implementing structured vaccination campaigns, especially in high-risk regions. This approach ensures better disease control and supports stable demand patterns within the foot and mouth disease vaccines industry. 

Expansion of Regional Vaccine and Antigen Banks 

The development of regional vaccine banks is improving procurement efficiency and availability. Countries across Asia-Pacific and the Middle East are establishing centralized reserves to manage sudden outbreaks. This trend is strengthening the foot and mouth disease vaccines market share by enabling bulk purchasing and reducing response time during emergencies. 

Adoption of DIVA Technologies 

The increasing use of DIVA (Differentiating Infected from Vaccinated Animals) technologies is another important factor influencing the foot and mouth disease vaccines market trends. These technologies allow better disease tracking and support international trade compliance, which is critical for livestock-exporting countries. Their adoption is also improving confidence in vaccination programs. 

Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights: https://www.mordorintelligence.com/ja/industry-reports/foot-and-mouth-disease-fmd-vaccines-market?utm_source=emailwire  

Foot and Mouth Disease Vaccines Market Segmentation 

By Product 

  • Modified/ Attenuated Live 
  • Inactivated (Killed) 
  • Others 

By Route of Administration 

  • Intramuscular 
  • Subcutaneous 

By Animal Type 

  • Cattle 
  • Pigs 
  • Sheep & Goats 
  • Others 

By Distribution Channel 

  • Veterinary Hospitals and Clinics 
  • Government Institutions 
  • Others 

By Geography 

  • Asia-Pacific 
  • Middle East and Africa 
  • South America 
  • Rest of the World 

Explore Our Full Library of Healthcare Research Report: 

https://www.mordorintelligence.com/market-analysis/healthcare?utm_source=emailwire   

Key Players in the Foot and Mouth Disease Vaccines Industry 

The competitive landscape of the foot and mouth disease vaccines market is moderately fragmented, with a mix of global companies and regional manufacturers. Large companies focus on research capabilities and global distribution networks, while regional players strengthen their position through localized production and government collaborations. 

Key Players: 

  • Biogénesis Bagó 
  • Boehringer Ingelheim GmbH 
  • VECOL S.A 
  • VETAL Animal Health Products 
  • Merck & Co. Inc. 

Explore more insights on foot and mouth disease vaccines competitive landscape: https://www.mordorintelligence.com/industry-reports/foot-and-mouth-disease-fmd-vaccines-market/companies?utm_source=emailwire  

Conclusion 

The foot and mouth disease vaccines market forecast indicates steady expansion driven by the increasing emphasis on preventive healthcare in livestock management. The transition toward routine vaccination, along with the establishment of vaccine banks, is creating a more structured and reliable demand environment within the industry. 

Technological developments, including improved vaccine formulations and diagnostic-compatible solutions, are expected to further enhance disease control efforts. These factors will continue to shape the foot and mouth disease vaccines market trends, especially in regions with high livestock density. 

Get detailed insights on the foot and mouth disease vaccines market: 

https://www.mordorintelligence.com/industry-reports/foot-and-mouth-disease-fmd-vaccines-market?utm_source=emailwire  

Industry Related Reports 

Biologics Market: 

The market is growing due to increasing demand for targeted therapies, rising prevalence of chronic diseases, and advancements in monoclonal antibodies and vaccine development. 

Get more insights: https://www.mordorintelligence.com/industry-reports/biologics-market?utm_source=emailwire 

Regenerative Medicine Market share: 

The market is projected to grow from USD 39.87 billion in 2026 to USD 91.94 billion by 2031 at a CAGR of 18.19%, driven by advancements in stem cell therapy, tissue engineering, and growing demand for personalized medicine. 

Get more insights: https://www.mordorintelligence.com/industry-reports/global-regenerative-medicines-market-industry?utm_source=emailwire 

OTC Drugs Market size: 

The market is expected to expand from USD 204.91 billion in 2026 to USD 256.18 billion by 2031 at a CAGR of 4.57%, fueled by increasing self-medication trends and accessibility of over-the-counter treatments. 

Get more insights: https://www.mordorintelligence.com/industry-reports/global-over-the-counter-otc-drugs-market-industry?utm_source=emailwire 

About Mordor Intelligence: 

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals. 

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics. 

For any inquiries or to access the full report, please contact: 

media@mordorintelligence.com
https://www.mordorintelligence.com/ 



Source link

You may also like

About Us

The APAC Weekly™ aggregates breaking news headlines on Asia Pacific countries (APAC) so that stakeholders of the region are informed. The APAC Weekly™ in conjunction with AsiaNewswire.Net™ publishes and distributes press releases to media in the APAC countries. For press release distribution to media, contact us today.

Apac Weekly™  is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC